Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. Efficient cFS-based On-board Lamberts Solution for DSMs

    SBC: Advanced Space LLC            Topic: T11

    Distributed Spacecraft Missions (DSM) architectures provide unique scientific and programmatic benefits including multipoint in-situ measurements, multi-angle viewpoints, and improved understanding of the connections between separately measured phenomena and their time variations. However, these missions impose significant operational demands on ground tracking resources and mission operators alik ...

    STTR Phase II 2019 National Aeronautics and Space Administration
  2. Energy and Velocity Analyzer for Distributions of Electric Rockets

    SBC: Plasma Controls, LLC            Topic: T2

    Plasma Controls, LLC (SBC) and Colorado State University (RI) will mature an energy and species plasma diagnostic for use with plasma thrusters. The combined Energy and Velocity Analyzer for Distributions of Electric Rockets, or the lsquo;E-VADERrsquo;, is needed especially for characterizing the plasma plume of Hall thrusters, where researchers desire to know ion energies and charged species frac ...

    STTR Phase I 2019 National Aeronautics and Space Administration
  3. Braided Thin-Ply Tapes

    SBC: Opterus Research and Development, Inc.            Topic: T12

    Opterus proposes to develop braided thin ply composite tapes. The tapes will be braided from ultra-thin spread-tow unidirectional carbon and glass ribbons and will enable a new source and form factor for thin-ply textiles. The resulting tapes will be especially useful for thin high strain composite space deployable structures where they will allow bias plies in long parts without requiring seams. ...

    STTR Phase I 2019 National Aeronautics and Space Administration
  4. Rapid Prototyping of Beam-Shaping Metamaterial Antennas via Additive Manufacturing of a Highly Conductive Filament

    SBC: Multi3D LLC            Topic: T8

    This NASA STTR Phase I proposal is aimed at rapid prototyping of antennas beam-shaping with metamaterials and metasurfaces through additive manufacturing of a highly conductive filament - Electrifi. The proposal includes the use of the highly conductive 3D printing filament, which was developed by Dr. Shengrong Ye, the principal investigator at the SBC - Multi3D and is at least 100 times more cond ...

    STTR Phase I 2019 National Aeronautics and Space Administration
  5. Hierarchical Metasurface Optics for Multiplexed Visible to Terahertz Cross-Band Systems

    SBC: Rochester Precision Optics, LLC            Topic: T8

    The aim of the proposed program is to design metasurface structures to manipulate electromagnetic waves of extremelynbsp;different frequencies, from visible light to THz.

    STTR Phase I 2019 National Aeronautics and Space Administration
  6. Correction of Splicing Defects in Cystic Fibrosis with Peptide-Oligonucleotide Conjugates and Small Molecule Enhancing Compounds

    SBC: Initos Pharmaceuticals LLC            Topic: NCATS

    ABSTRACT The pathogenesis of Cystic FibrosisCFis caused by mutations in the gene for CFTRa cAMP activated chloride channel that regulates salt and water transport in epithelial tissuesespecially those in the airwaysRecent progress has resulted in small molecule therapeutic agents that partially correct defects in the CFTR protein due to certain mutationsHoweverin a substantial fraction of CF patie ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  7. Development of a predictive moderate throughput assay to screen novel Designer Proline-rich antimicrobial peptide Chaperone protein inhibitors (DPCs) against multi-drug resistant pathogen

    SBC: Arrevus, Inc.            Topic: NIAID

    Multi drug resistantMDRbacterial infections represent a significant threat to public healthIt is estimated that the impact of antibiotic resistance will continue to grow resulting in a global economic burden of $trillion and causingmillion deaths annuallyMany of the therapeutics currently under development represent traditional antibiotic approaches or next generation antibiotics that will likely ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  8. Novel and potent SHIP1 inhibitors for improving hematologic recovery following myelosuppressive therapies

    SBC: Alterna Therapeutics, Inc.            Topic: NHLBI

    ABSTRACT Despite recent advances in targeting cancer cellschemotherapy remains a mainstay of oncologyextending survival and providing cures for many types of cancerHoweverchemotherapy that ablates or suppresses bone marrow cells can be debilitating even when combined with autologous hematopoietic stem cell transplantationHSCTThe treatment causes severe side effects such as anemianeutropenia and th ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  9. Automated CRISPR Screening Using the CellRaft Technology

    SBC: Cell Microsystems, Inc.            Topic: 400

    Project SummaryGenome wide functional genetics has been recently made possible by pooled library based CRISPR Casgene editing technologyBy randomly knocking out thousands of geneslarge scale screens can be conducted for functional geneticsdrug sensitivity and other phenotypesCurrently howeverthis forward genetic approach is largely relegated to live dead screens in mammalian cellsImproving the sop ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  10. Developing a Small Peptide to Control Autoimmune Inflammation In Type 1 Diabetes

    SBC: Op-T-Mune, Inc            Topic: NIAID

    TypeDiabetesT Daffects an ever growing populationWhile this disease typically has been associated with juvenilesthe disease in adult populations is rapidly increasingThe defining clinical component is insulin losswhich occurs because of sustained inflammation in the isletsAt present there is no means to prevent or reverse insulin lossA major inflammatory pathway in T D that contributes to insulin ...

    STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government